FibroBiologics closes USD 0.5 million private placement with chief scientific officer

• FibroBiologics closed a USD 0.5 million private placement with Chief Scientific Officer Hamid Khoja on Sept. 15, 2026.
• Sold 298,508 common shares with warrants for up to 298,508 more shares at a combined USD 1.68 per share-warrant.
• Warrants are immediately exercisable at USD 1.55 per share, expiring five years from issuance.
• Net proceeds earmarked for general corporate purposes, including working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609170830PR_NEWS_USPR_____DA50406) on September 17, 2026, and is solely responsible for the information contained therein.